glp-1 gip tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Tirzepatide Plano | Medical Weight

Spotlight: BPC157 The Wolverine Peptide What is BPC157

A systematic evaluation of time- and dose-dependent effects has been provided by Shihana et al., highlighting the importance of protocol optimization for reproducible pharmacological screening (Shihana et al., 2023)

Yamanishi Y, Boyle DL, Clark M et al (2002) Expression and regulation of aggrecanase in arthritis: the role of TGF-beta

doi:10.1007/s43032-020-00369-2 Kalyanaraman R, Pal L

L-carnitine ameliorated fasting-induced fatigue, hunger and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study

Do Not Stop Without Medical Advice If using these medications for diabetes, stopping abruptly without a replacement plan could lead to blood sugar spikes